Medicure is a pharmaceutical company focused on the development and commercialization of cardiovascular therapeutics for the U.S. market. Medicure’s current product portfolio includes:
Zypitamag™, is a statin medication with reduced potential for certain drug-drug interactions. Zypitamag is available in strengths of 2 mg and 4 mg.
ReDS™ is an easy-to-use, non-invasive system for the monitoring of lung fluid in patients with heart failure and other fluid management problems.
Aggrastat (tirofiban hydrochloride) injection is an IV antiplatelet used in the Cardiac Cath Lab during percutaneous coronary intervention (PCI) procedures.